-
1
-
-
0001070263
-
Economic aspects of controlled drug delivery
-
In: Mathiowitz E, ed., New York, NY: Wiley
-
Speers M, Bonnano C. Economic aspects of controlled drug delivery. In: Mathiowitz E, ed. Encyclopedia of Controlled Drug Delivery. New York, NY: Wiley; 1999:341-347.
-
(1999)
Encyclopedia of Controlled Drug Delivery
, pp. 341-347
-
-
Speers, M.1
Bonnano, C.2
-
2
-
-
0029076668
-
Osmotic drug delivery: A review of patent literature
-
DOI:10.1016/0168-3659(95)00013-X
-
Santus G, Baker WR. Osmotic drug delivery: a review of patent literature. J Control Release. 1995;35:1-21. DOI:10.1016/0168-3659(95)00013-X
-
(1995)
J Control Release
, vol.35
, pp. 1-21
-
-
Santus, G.1
Baker, W.R.2
-
3
-
-
0016830071
-
Elementary osmotic pump
-
PubMed DOI: 10.1002/jps.2600641218
-
Theeuwes F. Elementary osmotic pump. J Pharm Sci. 1975;64:1987-1991. PubMed DOI: 10.1002/jps.2600641218
-
(1975)
J Pharm Sci.
, vol.64
, pp. 1987-1991
-
-
Theeuwes, F.1
-
4
-
-
0025809463
-
Controlle d porosity solubility- and resin-modulated osmotic drug delivery systems for release of diltiazem hydrochloride
-
DOI: 10.1016/0168-3659(91)90047-H
-
Zentner GM, McClelland GA, Sutton SC. Controlle d porosity solubility- and resin-modulated osmotic drug delivery systems for release of diltiazem hydrochloride. J Control Release. 1991;16:237-244. DOI: 10.1016/0168-3659(91)90047-H
-
(1991)
J Control Release
, vol.16
, pp. 237-244
-
-
Zentner, G.M.1
McClelland, G.A.2
Sutton, S.C.3
-
5
-
-
0022408524
-
Osmotic flow through controlled porosity films: An approach to delivery of water-soluble compounds
-
DOI: 10.1016/0168-3659(85)90047-1
-
Zentner M, Rork GS, Himmelstein KJ. Osmotic flow through controlled porosity films: an approach to delivery of water-soluble compounds. J Control Release. 1985;2:217-229. DOI: 10.1016/0168-3659(85)90047-1
-
(1985)
J Control Release
, vol.2
, pp. 217-229
-
-
Zentner, M.1
Rork, G.S.2
Himmelstein, K.J.3
-
7
-
-
0029084991
-
Asymmetric-membrane tablet coatings for osmotic drug delivery
-
DOI: 10.1016/0168-3659(95)00028-7
-
Herbig SM, Cardinal JR, Korsmeyer RW, Smith KL. Asymmetric-membrane tablet coatings for osmotic drug delivery. J Control Release. 1995;35:127-136. DOI: 10.1016/0168-3659(95)00028-7
-
(1995)
J Control Release
, vol.35
, pp. 127-136
-
-
Herbig, S.M.1
Cardinal, J.R.2
Korsmeyer, R.W.3
Smith, K.L.4
-
8
-
-
0033007724
-
An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder
-
PubMed DOI: 10.1016/S0149-2918(00)88316-2
-
Goldenberg MM. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder. Clin Ther. 1999;21:634-642. PubMed DOI: 10.1016/S0149-2918(00)88316-2
-
(1999)
Clin Ther
, vol.21
, pp. 634-642
-
-
Goldenberg, M.M.1
-
9
-
-
0023732376
-
The pharmacokinetics of oxybutynin in man
-
PubMed DOI: 10.1007/BF00558247
-
Douchamps J, Derenne F, Stockis A, et al. The pharmacokinetics of oxybutynin in man. Eur J Clin Pharmacol. 1988;35:515-520. PubMed DOI: 10.1007/BF00558247
-
(1988)
Eur J Clin Pharmacol
, vol.35
, pp. 515-520
-
-
Douchamps, J.1
Derenne, F.2
Stockis, A.3
-
11
-
-
0032978860
-
Pharmacokinetics of an oral once-a-day controlled-release oxybutynin formulation compared with immediate-release oxybutynin
-
PubMed
-
Gupta SK, Sathyan G. Pharmacokinetics of an oral once-a-day controlled-release oxybutynin formulation compared with immediate-release oxybutynin. J Clin Pharmacol. 1999;39:289-296. PubMed
-
(1999)
J Clin Pharmacol
, vol.39
, pp. 289-296
-
-
Gupta, S.K.1
Sathyan, G.2
-
12
-
-
77957604506
-
Oxybutynin Chloride
-
Monograph 7089, In: Budavari S, ed., 12th ed. Whitehouse Station, NJ: Merck & Co
-
Monograph 7089. Oxybutynin Chloride. In: Budavari S, ed. The Merck Index. 12th ed. Whitehouse Station, NJ: Merck & Co; 1996.
-
(1996)
The Merck Index
-
-
-
13
-
-
0035897596
-
Chemical reactivity in solid-state pharmaceuticals: Formulation implications
-
PubMed DOI: 10.1016/S0169-409X(01)00102-8
-
Byrn SR, Xu W, Newman AW. Chemical reactivity in solid-state pharmaceuticals: formulation implications. Adv Drug Deliv Rev. 2001;48:115-136. PubMed DOI: 10.1016/S0169-409X(01)00102-8
-
(2001)
Adv Drug Deliv Rev.
, vol.48
, pp. 115-136
-
-
Byrn, S.R.1
Xu, W.2
Newman, A.W.3
-
14
-
-
0042884368
-
Development and evaluation of extended release formulations of isosorbide mononitrate based on osmotic technology
-
PubMed DOI: 10.1016/S0378-5173(03)00360-0
-
Verma RK, Kaushal AM, Garg S. Development and evaluation of extended release formulations of isosorbide mononitrate based on osmotic technology. IntJPharm. 2003;263:9-24. PubMed DOI: 10.1016/S0378-5173(03)00360-0
-
(2003)
Int J Pharm
, vol.263
, pp. 9-24
-
-
Verma, R.K.1
Kaushal, A.M.2
Garg, S.3
-
15
-
-
0021887806
-
The controlled porosity osmotic pump
-
DOI: 10.1016/0168-3659(85)90003-3
-
Zentner GM, Rork GS, Himmelstein KJ. The controlled porosity osmotic pump. J Control Release. 1985;1:269-282. DOI: 10.1016/0168-3659(85)90003-3
-
(1985)
J Control Release
, vol.1
, pp. 269-282
-
-
Zentner, G.M.1
Rork, G.S.2
Himmelstein, K.J.3
-
16
-
-
2342652446
-
Mathematical comparison of dissolution profiles
-
Moore JW, Flanner HH. Mathematical comparison of dissolution profiles. Pharm Technol. 1996;20:64-74.
-
(1996)
Pharm Technol
, vol.20
, pp. 64-74
-
-
Moore, J.W.1
Flanner, H.H.2
|